These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9694006)

  • 21. Clinical predictors of therapeutic response to clozapine in a sample of Turkish patients with treatment-resistant schizophrenia.
    Semiz UB; Cetin M; Basoglu C; Ebrinc S; Uzun O; Herken H; Balibey H; Algul A; Ates A
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1330-6. PubMed ID: 17618026
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment refractory schizophrenia].
    Vanelle JM
    Encephale; 1995 Jun; 21 Spec No 3():13-21. PubMed ID: 7628336
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased cortical inhibition in persons with schizophrenia treated with clozapine.
    Daskalakis ZJ; Christensen BK; Fitzgerald PB; Moller B; Fountain SI; Chen R
    J Psychopharmacol; 2008 Mar; 22(2):203-9. PubMed ID: 18308816
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simple schizophrenia in an adolescent.
    Valentí M; Castro-Fornieles J; Lázaro ML; Sugrañes G; Baeza I
    J Child Adolesc Psychopharmacol; 2009 Oct; 19(5):589-90. PubMed ID: 19877985
    [No Abstract]   [Full Text] [Related]  

  • 25. Clozapine reduces rehospitalization among schizophrenia patients.
    Pollack S; Woerner MG; Howard A; Fireworker RB; Kane JM
    Psychopharmacol Bull; 1998; 34(1):89-92. PubMed ID: 9564204
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Weight gain among schizophrenic patients treated with clozapine.
    Lamberti JS; Bellnier T; Schwarzkopf SB
    Am J Psychiatry; 1992 May; 149(5):689-90. PubMed ID: 1349460
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Developmental and neurologic correlates of treatment response in schizophrenia.
    Whelton CL; Cleghorn JM; Atley S; Durocher GJ; MacCrimmon D
    J Psychiatry Neurosci; 1992 Mar; 17(1):15-22. PubMed ID: 1349824
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Case report: neonatal delayed peristalsis after in-utero exposure to clozapine].
    Moreno-Bruna MD; de Montgolfier I; Chabaud M; Dommergues M
    Arch Pediatr; 2012 Sep; 19(9):913-6. PubMed ID: 22884999
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Substance abuse in clozapine-treated schizophrenic patients.
    Sand PG; Soyka M
    J Neuropsychiatry Clin Neurosci; 1997; 9(4):626-7. PubMed ID: 9447510
    [No Abstract]   [Full Text] [Related]  

  • 30. [Pregnancy and labor complications--their significance in the development of schizophrenic psychoses].
    Stöber G; Franzek E; Beckmann H
    Fortschr Neurol Psychiatr; 1993 Oct; 61(10):329-37. PubMed ID: 8258430
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlated changes in symptoms and neurotransmitter indices during maintenance treatment with clozapine or conventional neuroleptics in adolescents and young adults with schizophrenia.
    Schulz E; Fleischhaker C; Remschmidt HE
    J Child Adolesc Psychopharmacol; 1996; 6(2):119-31. PubMed ID: 9231304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ["Polydipsia, intermittent hyponatremia and psychoses" syndrome: a diagnosis and therapeutic management of a case].
    Assouly-Besse F; Seletti B; Lamarque I; Elghozi D; Petitjean F
    Ann Med Psychol (Paris); 1996 Jun; 154(4):259-63. PubMed ID: 8929056
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The electroencephalographic sleep pattern in schizophrenic patients treated with clozapine or classical antipsychotic drugs.
    Wetter TC; Lauer CJ; Gillich G; Pollmächer T
    J Psychiatr Res; 1996; 30(6):411-9. PubMed ID: 9023785
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cerebral morphometry and clozapine treatment in schizophrenia.
    Bilder RM; Wu H; Chakos MH; Bogerts B; Pollack S; Aronowitz J; Ashtari M; Degreef G; Kane JM; Lieberman JA
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():53-6. PubMed ID: 7961574
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Auditory P50 in schizophrenics on clozapine: improved gating parallels clinical improvement and changes in plasma 3-methoxy-4-hydroxyphenylglycol.
    Nagamoto HT; Adler LE; McRae KA; Huettl P; Cawthra E; Gerhardt G; Hea R; Griffith J
    Neuropsychobiology; 1999; 39(1):10-7. PubMed ID: 9892854
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prescribing clozapine to that patient: between anarchistic empiricism and arbitrary classification].
    Uhl R
    Encephale; 1996 Dec; 22 Spec No 6():33-4. PubMed ID: 9102318
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between regional brain volumes and clozapine response in schizophrenia.
    Lauriello J; Mathalon DH; Rosenbloom M; Sullivan EV; Faustman WO; Ringo DL; Lim KO; Pfefferbaum A
    Biol Psychiatry; 1998 Jun; 43(12):879-86. PubMed ID: 9627742
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparison of the effect of clozapine with typical neuroleptics on cognitive function in neuroleptic-responsive schizophrenia.
    Lee MA; Jayathilake K; Meltzer HY
    Schizophr Res; 1999 May; 37(1):1-11. PubMed ID: 10227103
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pregnancy infections in mothers of chronic schizophrenic patients. The significance of differential nosology].
    Stöber G; Franzek E; Beckmann H
    Nervenarzt; 1994 Mar; 65(3):175-82. PubMed ID: 8177358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of clozapine on completed suicide.
    Sernyak MJ; Desai R; Stolar M; Rosenheck R
    Am J Psychiatry; 2001 Jun; 158(6):931-7. PubMed ID: 11384902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.